N Masuda

CPT-11: a new derivative of camptothecin for the treatment of refractory or relapsed small-cell lung cancer.

N Masuda, M. Fukuoka, Y Kusunoki et al. · Journal of Clinical Oncology · 1992 · 452 citations

Medicine, Oncology, Pharmacology +8

A phase II study of CPT-11, a new derivative of camptothecin, for previously untreated non-small-cell lung cancer.

M. Fukuoka, H Niitani, Atsushi Suzuki et al. · Journal of Clinical Oncology · 1992 · 435 citations

Medicine, Oncology, Pharmacology +16

Phase I Study of Weekly Intravenous Infusions of CPT-11, a New Derivative of Camptothecin, in the Treatment of Advanced Non-Small-Cell Lung Cancer

S. Negoro, M. Fukuoka, N Masuda et al. · JNCI Journal of the National Cancer Institute · 1991 · 274 citations

Medicine, Oncology, Pharmacology +14

Randomised phase III trial of irinotecan combined with cisplatin for advanced non-small-cell lung cancer

Shunichi Negoro, N Masuda, Y Takada et al. · British Journal of Cancer · 2003 · 153 citations · Full text

Medicine, Oncology, Pharmacology +11

CPT-11 in combination with cisplatin for advanced non-small-cell lung cancer.

N Masuda, M. Fukuoka, M Takada et al. · Journal of Clinical Oncology · 1992 · 141 citations

Pharmacy, Oncology, Pharmacology +17